アイコン	機能
💬	このアイコンの近くの文字列は、マウスオーバーで説明がポップアップ表示されます。また、このアイコンをクリックすると、説明ウィンドウが表示されます。
	このアイコンが表示されているリンクは、外部のサイトへのリンクになります。
	このアイコンをクリックすると、このアイコンのある項目で表がソートされます（数値大小、またはアルファベット順）。クリックごとに昇順と降順が切り替わります。
	100文字より長い文字列が全表示、または折りたたまれます。
	表示されている表の内容が、"table.csv"というファイル名でダウンロードされます。

KEGG DRUG

Search results

No.

薬物名（臨床試験情報から抽出）

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

指定難病告示番号

Human interferon beta
(D03304)

1件: Human interferon beta

1件: Interferon beta (D03304) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

2件: 13, 26 💬

告示番号	日本語名	英語名
13	多発性硬化症／視神経脊髄炎;多発性硬化症;視神経脊髄炎;Balo病;バロー同心円硬化症	Multiple sclerosis/Neuromyelitis optica
26	HTLV-1関連脊髄症	HTLV-1-associated myelopathy

Human interferon beta 1a (Rebif)
(D03304)

1件: Human interferon beta

1件: Interferon beta (D03304) 💬

2件: IFNAR1,
IFNAR2 💬

1件: 13 💬

Human interferon beta-1a and glatiramer acetate
(D03304)

4件: Acetate,
Glatiramer,
Human interferon beta,
Interferon beta-1a

3件: Interferon beta (D03304),
Glatiramer acetate ,
Interferon beta-1a 💬

Name	Other Names
Interferon beta	Feron インターフェロンベータ
Glatiramer acetate	Copaxone GLATOPA グラチラマー酢酸塩コパキソン
Interferon beta-1a	Avonex Rebif インターフェロンベータ-1a アボネックス

22件: HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G,
IFNAR1,
IFNAR2 💬

Name	Full Name
HLA-A	HLA class I histocompatibility antigen, A alpha chain isoform A*03:01:01:01 precursor
HLA-B	major histocompatibility complex, class I, B precursor
HLA-C	HLA class I histocompatibility antigen, C alpha chain precursor
HLA-DMA	HLA class II histocompatibility antigen, DM alpha chain precursor
HLA-DMB	HLA class II histocompatibility antigen, DM beta chain precursor
HLA-DOA	HLA class II histocompatibility antigen, DO alpha chain precursor
HLA-DOB	HLA class II histocompatibility antigen, DO beta chain precursor
HLA-DPA1	HLA class II histocompatibility antigen, DP alpha 1 chain precursor
HLA-DPB1	HLA class II histocompatibility antigen, DP beta 1 chain precursor
HLA-DQA1	HLA class II histocompatibility antigen, DQ alpha 1 chain precursor
HLA-DQA2	HLA class II histocompatibility antigen, DQ alpha 2 chain precursor
HLA-DQB1	HLA class II histocompatibility antigen, DQ beta 1 chain isoform 2 precursor
HLA-DRA	HLA class II histocompatibility antigen, DR alpha chain precursor
HLA-DRB1	major histocompatibility complex, class II, DR beta 1 precursor
HLA-DRB3	major histocompatibility complex, class II, DR beta 3 precursor
HLA-DRB4	major histocompatibility complex, class II, DR beta 4 precursor
HLA-DRB5	major histocompatibility complex, class II, DR beta 5 precursor
HLA-E	HLA class I histocompatibility antigen, alpha chain E precursor
HLA-F	HLA class I histocompatibility antigen, alpha chain F isoform 2 precursor
HLA-G	HLA class I histocompatibility antigen, alpha chain G isoform 2 precursor
IFNAR1	interferon alpha/beta receptor 1 isoform 2 precursor
IFNAR2	interferon alpha/beta receptor 2 isoform a precursor

44件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Coronavirus disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬

1件: 13 💬

New Formulation of rebif - human interferon beta-1a
(D03304)

2件: Human interferon beta,
Interferon beta-1a

2件: Interferon beta (D03304),
Interferon beta-1a 💬

2件: IFNAR1,
IFNAR2 💬

1件: 13 💬

Recombinant human interferon beta
(D03304)

1件: Human interferon beta

1件: Interferon beta (D03304) 💬

2件: IFNAR1,
IFNAR2 💬

1件: 13 💬

Recombinant human interferon beta-1a
(D03304)

2件: Human interferon beta,
Interferon beta-1a

2件: Interferon beta (D03304),
Interferon beta-1a 💬

2件: IFNAR1,
IFNAR2 💬

1件: 26 💬